The Latest Breaking News from FDA

Texas Declares Emergency as Flesh-Eating Parasite Returns for the First Time in Nearly 60 Years and Spreads to Pet Dogs

USDA confirms New World screwworm cases across four Texas counties and Lea County, New Mexico. Gov. Abbott activated emergency operations and quarantines are in effect.

Medical Daily · Jun 22

Major New Scientific Review Concludes Vaping Likely Causes Lung and Oral Cancer in People Who Vape

A peer-reviewed UNSW Sydney review published in Carcinogenesis June 21, 2026, concludes nicotine e-cigarettes are likely to cause lung and oral cancers.

Medical Daily · Jun 22

3 Biotech Firms With Major Potential Catalysts in the Coming Months

The pharmaceutical industry is known for big risks and big rewards among investors; those willing to take on the risk may want to watch these firms.

MarketBeat · Jun 21

FDA Authorized an OTC Treatment for New World Screwworm in Pets — Here's How to Use Nitenpyram if Your Dog or Cat Is Infested

FDA issued EUA for generic nitenpyram June 11, 2026 to treat New World screwworm in dogs and cats. CDC Level 3 EOC active. 12+ animal cases confirmed in TX and NM.

Medical Daily · Jun 19

FDA Approves First Generic Baloxavir (Xofluza): Single-Dose Flu Treatment Now Available at Generic Price

FDA approved the first generic baloxavir marboxil (Xofluza) on June 17, 2026. Norwich Pharmaceuticals developed the single-dose flu treatment for patients 5 and older.

Medical Daily · Jun 19

Huntington's Disease Gene Therapy AMT-130 Is on Track for FDA Approval After uniQure Reaches Regulatory Agreement

uniQure announced June 17, 2026: FDA agreed that 3-year AMT-130 Phase I/II data supports an accelerated approval BLA for Huntington's disease. BLA submission planned Q3 2026.

Medical Daily · Jun 19

Alembic Pharma gets tentative nod from USFDA for generic cancer drug

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketing exclusivity. Alembic previously received tentative approval for the 15mg strength. Binimetinib…

The Economic Times · Jun 19

USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observations

Jubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washington, received eight observations. These observations do not involve sterility assurance concerns. The company will submit its response to the US health regulator within 15 business days. Jubilant Pharmova is committed to addressing…

The Economic Times · Jun 19

Tennessee Became the First State to Let Pharmacies Sell Ivermectin without a Prescription. Here's What That Looks Like Now.

KFF Health News June 17 investigation: Tennessee pharmacies sell ivermectin 10–21x standard potency via one anti-vaccine doctor's blanket prescriptions. 60+ poison center calls in 2025.

Medical Daily · Jun 19

Premature Infants in NICUs Are Among the Most DEHP-Exposed Humans on Earth — and the New Anxiety Study Makes That Urgent

NICU premature infants face intensive DEHP exposure via PVC medical tubing and IV bags. ENDO 2026 data shows prenatal/postnatal DEHP causes lasting anxiety. Here's the accountability gap.

Medical Daily · Jun 19